After 15 years of HPV vaccination programmes across Europe, growing evidence confirms their long-term effectiveness. A new report highlights steady progress in cancer prevention efforts.
Tick‑borne encephalitis is one of the most dangerous viral diseases spread in Europe. Researchers have discovered how the viruses replicate inside cells, paving the way for future treatments.
Bacterial infections can be difficult to distinguish from viral infections and inflammation, but a simple breath test may change that. This could reduce unnecessary antibiotic prescriptions.
Vaccination against human papillomavirus (HPV) reduces the risk of cervical cancer for at least 18 years, according to a new study. There were no signs of waning protection over time.
The immune system’s reaction to the common Epstein-Barr virus (EBV) can ultimately damage the brain and contribute to multiple sclerosis (MS), a new study shows.
Researchers from Osaka have developed a simple and efficient system for understanding the functions of specific norovirus genes, providing new avenues for developing antivirals and vaccines.
In response to rising H5N1 avian influenza cases in Europe, a new framework aims to help countries detect and respond to spillover to humans – from enhanced surveillance to pandemic preparedness.
A team of researchers comprehensively catalogued a new collection of bacteria-eating viruses called phages. These phages could be used to combat Klebsiella pneumoniae - a serious threat in hospitals.
More than a decade of protection against the human papillomavirus (HPV): a new study confirms the long-term effectiveness of the HPV vaccine to prevent development of cervical cancer and pre-cancer.
After a bout of influenza or Covid, the risk of heart attack or stroke may rise dramatically, and chronic infections may increase the long-term risk of serious cardiovascular disease events.
HIV manages to persist in the body for decades after infection and treatment. Now, researchers discovered that the virus cloaks itself in the DNA of infected cells using unique DNA patterns.
When the many protect the few: An expert explains the premise of herd immunity, and how vaccinations apply the priciple in preventing communicable diseases, notably in the complete eradication of smallpox.
Climate change enables mosquito-borne pathogens such as the chikungunya and West Nile virus to establish themselves in Europe. ECDC experts explain how EU countries can adapt to this ‘new normal’.
After an infection with the coronavirus Sars-CoV-2, the virus is able to persist at low levels in the brainstem, new research finds. This helps explain some of the enduring neurological symptoms.
Common respiratory infections such as influenza and Covid-19 can awaken dormant breast cancer cells that have spread to the lungs, setting the stage for new metastatic tumors, new research finds.
When someone is infected with a virus, traces of it are shed in their bodily waste and end up in the sewage system. Thus, combined wastewater and individual testing can benefit public health response.
After the Covid-19 pandemic, face masks have become less common. However, those who still need to wear a mask often suffer from discomfort due to restricted breathing. New research could change this.
Ending epidemics like HIV, tuberculosis, hepatitis and STIs by 2030 is a key health goal for Europe. Although progress has been made, many EU countries are not on track to meet the goals, experts say.
Due to the effects of climate change, dengue is spreading worldwide. Now, researchers have developed a 'dengue-on-a-chip' model that helps study the virus more effectively.
